FDA Inspection 1042065 — David Soper, M.D.
The FDA completed an inspection of David Soper, M.D. on Feb 8, 2018 in Charleston, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Charleston, SC (United States)
Additional Details
Clinical Investigator (CI)